TXNIP and metabolic dysfunction-associated steatotic liver disease: However, the extent to which the anti-obesity effects of SalA exerted through regulating TXNIP-mediated signaling implicated in hepatic lipogenesis account for the overall improvement of NAFLD in HFD-fed rats remains to be further explored.